Cellular and molecular mechanisms of growth hormone action on skeletal muscle: Implications for treatment of age-associated sarcopenia

Journal of Anti-Aging Medicine

Volumn 5, Issue 1, 2002, Pages 27-40

  Quinn, Lebris S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INTERLEUKIN 15; MYOSTATIN; SOMATOMEDIN; SOMATOMEDIN RECEPTOR;

AGING; APOPTOSIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; DRUG MECHANISM; HORMONE ACTION; HUMAN; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE MASS; MYOBLAST; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STEM CELL;

EID: 0036096279     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/109454502317629273     Document Type: Review

References (117)

1. Skeletal muscle weakness in old age: Underlying mechanisms
2. Effect of aging on human skeletal muscle and motor function
3. Aging and muscle loss
4. Effects of physical activity on health status in older adults. II. Intervention studies
5. A multifactorial intervention to reduce the risk of falling among elderly people living in the community
6. Trophic factor supplementation: Effect on the age-associated changes in body composition
7. The endocrinology of aging
8. Human aging, muscle mass, and fiber type composition
9. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro
10. The somatomedin hypothesis: 2001
11. Mice carrying null mutations of the gene encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
12. IGF-I is required for normal embryonic growth in mice
13. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat
14. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice
15. Normal growth and development in the absence of hepatic insulin-like growth factor I
16. Liver-derived insulin-like growth factor (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
17. Insulin-like growth factor-I (IGF-I) analogue, LR3IGF-I, ameliorates the loss of body weight but not of skeletal muscle during food restriction
18. Altered body composition and increased frequency of diverse maliganancies in insulin-like growth factor-II transgenic mice
19. Genetics of Beckwith-Wiedemann syndrome-associated tumors: Common genetic pathways
20. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice
21. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice
22. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle
23. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats
24. The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia
25. Anabolic effects of recombinant insulin-like growth factor-I in cachextic patients with the acquired immunodeficiency syndrome
26. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women
27. Insulin-like growth factor I (IGF-I): A molecular basis for endocrine versus local action?
28. Induction of mRNA for IGF-I and -II during growth hormone-stimulated muscle hypertrophy
29. Effect of training and growth hormone suppression on insulin-like growth factor I mRNA in young rats
30. Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch
31. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men
32. Molecular and cellular aspects of the insulin-like growth factor I receptor
33. Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells
34. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation
35. Insulin-like growth factors in muscle development. Expression of IGF-I, the IGF receptor, and an IGF binding protein during myoblast differentiation
36. Insulin/IGF-1 hybrid receptors: Implications for the dominant-negative phenotype in syndromes of insulin resistance
37. The type II IGF receptor has low affinity for IGF-I analogs: Pleiotropic actions of IGFs on myoblasts are apparently mediated by the type I receptor
38. Type-1 IGF receptor overexpression produces dual effects on myoblast proliferation and differentiation
39. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
40. The molecular and cellular biology of insulin-like growth factor II
41. Genetic analsis of genomic imprinting: An Imprintor-1 gene controls inactivation of the paternal copy of the mouse Tme locus
42. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK
43. The embryonic origin of muscle
44. Cellular aspects of muscle growth: Myogenic cell proliferation
45. Adaptation of rat extensor digitorum longus muscle to gamma irradiation and overload
46. Comparative aspects of muscle fiber types in fetuses of the normal and "double-muscled" cattle
47. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member
48. Growth hormone and the insulin-like growth factor system in myogenesis
49. Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures
50. Retrovirally mediated overexpression of IGFBP-4: Evidence that IGF is required for skeletal muscle differentiation
51. Insulin-like growth factor-mediated muscle cell survival: Central roles for Akt and cyclin-dependent kinase inhibitor p21
52. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
53. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways
54. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: Dominant negative p85 expression blocks differentiation of L6E9 muscle cells
55. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts
56. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells
57. Insulin-like growth factor (IGF)-binding protein-related protein-1: An autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF
58. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor
59. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor
60. Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor
61. The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy
62. Plasticity of myonuclear number in hypertrophied and atrophied mammalian skeletal muscle fibers
63. Regulation of skeletal muscle fiber size, shape, and function
64. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth
65. Activation state of muscle satellite cells isolated from steers implanted with a combined trenbolone acetate and estradiol implant
66. Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus muscle
67. Satellite cell activity is required for hypertrophy of overloaded adult rat muscle
68. Effect of radiation on satellite cell activity and protein expression in overloaded mammalian skeletal muscle
69. DNA fragmentation occurs in skeletal muscle during tumour growth: A link with cancer
70. Myonuclear loss in atrophied soleus muscle fibers
71. The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats
72. Effect of the beta-adrenergic agonist L644,969 on muscle growth, endogenous proteinase activities, and postmortem proteolysis in wether lambs
73. Satellite cells in innervated and denervated muscles treated with clenbuterol
74. Interleukin-15: A novel anabolic cytokine for skeletal muscle
75. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats
76. Role of insulin-like growth factors and growth hormone in reversing catabolic states
77. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor-I
78. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
79. Calcineurin activity is required for the initiation of skeletal muscle differentiation
80. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression
81. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function
82. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle cells
83. Over-expression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy
84. Growth hormone/IGF-I and/or resistive exercise maintains myonuclear number in hindlimb unweighted muscles
85. Long-term insulin-like growth factor-I expression in skeletal muscles attenuates the enhanced in vitro proliferation ability of the resident satellite cells in transgenic mice
86. Myoblast senescence in muscular dystrophy
87. Replicative potential and telomere length in human skletal muscle: Implications for satellite cell-mediated gene therapy
88. Skeletal muscle regeneration and the mitotic clock
89. Complexity of age-related change in skeletal muscle
90. Distribution of protein turnover changes with age in humans as assessed by whole-body magnetic resonance image analysis to quantify tissue volumes
91. Myofibrillar protein synthesis in young and old men
92. Biology of cachexia
93. Cachexia
94. Cancer cachexia: A key role for TNF?
95. Increased mortality associated with growth hormone treatment in critically ill adults
96. IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats
97. Insulin-like growth factor I reduces ubiquitin and ubiquitin-conjugating enzyme gene expression but does not inhibit muscle proteolysis in septic rats
98. Effect of insulin-like growth factor I in murine musclular dystrophy
99. Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism
100. Regulation of protein turnover by recombinant human insulin-like growth factor-I in L6 myotube cultures
101. Effects of serum and insulin-like growth factor I on protein degradation and protease gene expression in rat L8 myotubes
102. Assessment of the role of the glucocorticoid system in aging processes and in the action of food restriction
103. Sensitivity and protein turnover responses to glucocorticoids are different in skeletal muscle from adult and old rats
104. Glucocorticoid effects on insulin- and IGF-I regulated muscle protein metabolism during aging
105. Effects of growth hormone on muscle regeneration and IGF-I concentration in old rats
106. Retarded myogenic cell replication in regenerating skeletal muscles of old mice: An autoradiographic study in young and old BALB/c and SJL/J mice
107. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle
108. Skeletal muscle satellite cells: Changes in proliferation potential as a function of age
109. Paracrine stimulation of senescent satellite cell proliferation by factors released by muscle or myotubes from young mice
110. Muscle transplantation between young and old rats: Age of host determines recovery
111. Age-associated alterations in cardiac and skeletal muscle glucose transporters, insulin and IGF-1 receptors, and PI3-kinase protein contents in the C57BL/6 mouse
112. Humoral immunity in aging
113. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration
114. Clenbuterol in the prevention of muscle atrophy: A study of hindlimb-unweighted rats
115. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy
116. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting
117. Interleukin-15 mediates reciprocal regulation of adipose tissue and muscle mass: A potential role in body weight control